BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12

• Press Releases

  Orion Pharma announces the initiation of TEADES Phase 2 trial of ODM-212 in Malignant Pleural Mesothelioma (MPM) and Epithelioid Hemangioendothelioma (EHE)

  January 8, 2026

   · 

  3 min read
• Press Releases

  Agomab Announces Positive Phase 1 Interim Results with AGMB-447 in Healthy Participants and Initiation of Idiopathic Pulmonary Fibrosis Cohort

  January 8, 2026

   · 

  4 min read
• Press Releases

  Saluda Medical Receives Regulatory Approval for EVA™ Sensing Technology in Europe with recognition in Australia

  January 8, 2026

   · 

  4 min read
• Press Releases

  Complement Therapeutics Announces FDA Fast Track Designation for CTx001 for the Treatment of Geographic Atrophy Secondary to AMD

  January 8, 2026

   · 

  2 min read
• Press Releases

  Diagonal Therapeutics Announces Oversubscribed $125 Million Series B Financing to Advance Clinical Development of Disease-Modifying, Clustering Antibody Pipeline

  January 8, 2026

   · 

  5 min read
• Press Releases

  Telix to Present Pipeline and Commercial Portfolio Overview at J.P. Morgan Healthcare Conference

  January 8, 2026

   · 

  5 min read
• Press Releases

  Aclarion Provides 2025 Update and 2026 Corporate Outlook

  January 8, 2026

   · 

  7 min read
• Press Releases

  NervGen Pharma Begins Trading on Nasdaq Today

  January 8, 2026

   · 

  6 min read
• Press Releases

  EpiBiologics Closes $107M Series B to Advance Pipeline of Novel Bispecific Antibodies to Selectively Degrade Extracellular Protein Targets in Oncology and Immunology

  January 8, 2026

   · 

  3 min read
• Press Releases

  Abbelight Announces Successful Series B Investment led by AVANT BIO to Accelerate Imaging Innovation and Scale Adoption Across a Broader Customer Base

  January 8, 2026

   · 

  2 min read